These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9415017)

  • 41. Kawasaki disease complicated by acute myocardial infarction 9 years after onset.
    Ohyagi A; Hirose K; Tsujimoto S; Doyama K; Watanabe Y; Nakai T
    Am Heart J; 1985 Sep; 110(3):670-2. PubMed ID: 4036795
    [No Abstract]   [Full Text] [Related]  

  • 42. [Thrombolytic therapy of myocardial infarction (discussion)].
    Nihon Naika Gakkai Zasshi; 1992 Aug; 81(8):1236-48. PubMed ID: 1431465
    [No Abstract]   [Full Text] [Related]  

  • 43. Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction.
    Kirtane AJ; Weisbord A; Karmpaliotis D; Murphy SA; Giugliano RP; Cannon CP; Antman EM; Ohman EM; Roe MT; Braunwald E; Gibson CM;
    Am J Cardiol; 2005 Jan; 95(2):224-7. PubMed ID: 15642554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiographic studies demonstrating the need for conjunctive anticoagulation.
    Bleich SD
    Coron Artery Dis; 1996 Jul; 7(7):516-21. PubMed ID: 8913669
    [No Abstract]   [Full Text] [Related]  

  • 45. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial.
    Murphy SA; Dauterman K; de Lemos JA; Kermgard S; Antman EM; Braunwald E; Gibson CM;
    Am Heart J; 2003 Jul; 146(1):42-7. PubMed ID: 12851606
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful thrombolytic therapy for acute myocardial infarction in a patient with the antiphospholipid antibody syndrome.
    Harpaz D; Glikson M; Sidi Y; Hod H
    Am Heart J; 1991 Nov; 122(5):1492-5. PubMed ID: 1951025
    [No Abstract]   [Full Text] [Related]  

  • 48. Acute myocardial infarction and 30-year coronary aneurysm follow-up by serial angiography in a young adult with Kawasaki disease.
    Matsushita K; Tamura T; Nishiga M; Kaitani K; Izumi C; Nakagawa Y
    Cardiovasc Interv Ther; 2015 Apr; 30(2):142-6. PubMed ID: 24729026
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toward achieving optimal reperfusion: revisiting thrombolysis.
    Becker RC
    Coron Artery Dis; 1994 Aug; 5(8):717-22. PubMed ID: 8000626
    [No Abstract]   [Full Text] [Related]  

  • 50. Impact of early accelerated dose tissue plasminogen activator on in-hospital patency of the infarcted vessel in patients with acute right ventricular infarction.
    Giannitsis E; Potratz J; Wiegand U; Stierle U; Djonlagic H; Sheikhzadeh A
    Heart; 1997 Jun; 77(6):512-6. PubMed ID: 9227293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myocardial infarction in a 35-day-old infant with incomplete Kawasaki disease and chicken pox.
    Kossiva L; Papadopoulos M; Lagona E; Papadopoulos G; Athanassaki C
    Cardiol Young; 2010 Oct; 20(5):567-70. PubMed ID: 20633312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Roles of the red cell distribution width and neutrophil/lymphocyte ratio in predicting thrombolysis failure in patients with an ST-segment elevation myocardial infarction.
    Baysal E; Çetin M; Yaylak B; Altntaş B; Altndağ R; Adyaman Ş; Altaş Y; Kaya İ; Sevuk U
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):274-8. PubMed ID: 25396765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute myocardial infarction due to a regressed giant coronary aneurysm as possible sequela of Kawasaki disease.
    Shiraishi J; Sawada T; Tatsumi T; Azuma A; Nakagawa M
    J Invasive Cardiol; 2001 Jul; 13(7):569-72. PubMed ID: 11435648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low tissue plasminogen activator relative to plasminogen activator inhibitor-1 as a marker of cardiac complication in children with Kawasaki disease.
    Sakai M; Asayama K; Otabe T; Kohri T; Shirahata A
    Clin Appl Thromb Hemost; 2001 Jul; 7(3):214-8. PubMed ID: 11441982
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombus migration following intracoronary tissue plasminogen activator.
    Rudoff J; Strauss R
    Cathet Cardiovasc Diagn; 1992 Jun; 26(2):161-2. PubMed ID: 1485896
    [No Abstract]   [Full Text] [Related]  

  • 56. Lack of association between raised serum lipoprotein(a) and thrombolysis.
    Tranchesi B; Maranhao R; Cobbaert C; Vanhove P; Verstraete M
    Lancet; 1990 Dec 22-29; 336(8730):1587-8. PubMed ID: 1979405
    [No Abstract]   [Full Text] [Related]  

  • 57. Conservative management after thrombolysis: the strategy of choice.
    Geltman EM
    J Am Coll Cardiol; 1990 Dec; 16(7):1535-7. PubMed ID: 2123902
    [No Abstract]   [Full Text] [Related]  

  • 58. Case review: thrombolysis in acute myocardial infarction.
    Ernest JK
    J Emerg Nurs; 1990; 16(3 Pt 2):212-8. PubMed ID: 2115091
    [No Abstract]   [Full Text] [Related]  

  • 59. Front-loaded accelerated infusions of tissue plasminogen activator: putting a better foot forward.
    Vaughan DE; Braunwald E
    J Am Coll Cardiol; 1992 Apr; 19(5):1076-8. PubMed ID: 1552098
    [No Abstract]   [Full Text] [Related]  

  • 60. Does plasma endothelin during thrombolysis depend on infarct size? A pilot study.
    Di Pasquale P; Paterna S; Parrinello G; Bucca V; Pipitone F; Tricoli G; Licata G
    Cardiovasc Drugs Ther; 1995 Dec; 9(6):831-2. PubMed ID: 8850391
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.